Cocoa flavanols (primarily epicatechin) have the strongest cardiovascular evidence of any flavonoid — a 2012 Cochrane review of 20 RCTs confirmed significant blood pressure reduction, and the COSMOS trial (21,442 participants) found cocoa extract reduced cardiovascular death by 27%. EFSA (European Food Safety Authority) approved the health claim: "cocoa flavanols help maintain endothelium-dependent vasodilation." Our research shows the critical insight: standard dark chocolate and cocoa powder are NOT reliable sources because Dutch processing (alkalization) destroys 60-90% of flavanols. Only standardized cocoa flavanol supplements deliver consistent doses.
Epicatechin (the dominant cocoa flavanol) works through: (1) eNOS activation — directly stimulates endothelial nitric oxide synthase, increasing NO production by 30-40%, causing vasodilation and blood pressure reduction; (2) endothelin-1 suppression — reduces the vasoconstrictor signal; (3) antiplatelet activity — reduces thromboxane A2 synthesis and platelet aggregation; (4) insulin sensitivity — epicatechin activates insulin receptor substrate 1 (IRS-1) and GLUT4 translocation; (5) cerebral blood flow — NO-mediated vasodilation specifically in brain microvessels increases hippocampal perfusion. The cardiovascular mechanism is pharmacologically robust — cocoa flavanols produce a sustained, dose-dependent NO increase that explains the consistent BP reduction across 20+ trials.
No critical interactions identified.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.